In an unprecedented and strategic move, the U.S. Food and Drug Administration (FDA) has granted permission for the temporary import of an unapproved Chinese cancer drug. The decision comes amid a growing shortage of vital cancer drugs in the US, notably cisplatin, a widely used chemotherapy medication. The crisis has prompted the FDA to consider unconventional approaches, and this move stands as testament to that flexibility.
Early diagnosis through cancer screening can offer a better chance of cure, and preventive care can reduce the risk of getting cancer in the first place.
Caloocan City Mayor Dale Gonzalo “Along” Malapitan, announced the launch of a free vaccination program to combat various strains of the human papillomavirus (HPV).
In conclusion, Herbosa’s advocacy epitomises a concerted effort to ensure accessibility and equity in healthcare access for all Filipinos. The DOH strives to catalyse a paradigm shift towards preventive care and bolster health outcomes nationwide. This is exhibited by advocating for the integration of essential preventive screenings into PhilHealth’s benefit packages and simplifying access for vulnerable populations such as PWDs. Guaranteeing that preventive screenings are readily accessible and financially feasible for all segments of society remains paramount to alleviating disease burden and propelling public health advancements in the Philippines. Herbosa’s initiatives underscore an unwavering commitment to realising universal health coverage and advancing health equity for every Filipino, irrespective of circumstance or background.
Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This week’s bulletin covers HIV cases in the Philippines, illegal eczema creams in Singapore and more.
